ADMA Biologics (ADMA)
(Delayed Data from NSDQ)
$13.58 USD
-0.18 (-1.31%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $13.73 +0.15 (1.10%) 7:58 PM ET
1-Strong Buy of 5 1
F Value A Growth D Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/14/2024
Time: -- |
6/2024 | $0.08 | 0.00% |
Earnings Summary
For their last quarter, ADMA Biologics (ADMA) reported earnings of $0.08 per share, beating the Zacks Consensus Estimate of $0.05 per share. This reflects a positive earnings surprise of 60.00%. Look out for ADMA's next earnings release expected on August 14, 2024. For the next earning release, we expect the company to report earnings of $0.08 per share, reflecting a year-over-year increase of 500%.
Earnings History
Price & Consensus
Zacks News for ADMA
What's in Store for ADMA Biologics (ADMA) in Q2 Earnings?
ADMA: What are Zacks experts saying now?
Zacks Private Portfolio Services